KRAS <sup>G12D</sup> -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC PatientsValerie S. LeBleu, Shubham Pant|medRxiv|2025Cited by 16